Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
RNXT RenovoRx
3.100+0.080+2.65%
Close
02/03 16:00 ET
3.1000.0000.00%
Post Mkt Price 02/03 18:10 ET
High
3.250
Open
3.040
Turnover
133.17K
Low
2.950
Pre Close
3.020
Volume
42.87K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
RenovoRx to Present at the Sequire Biotechnology Virtual Conference on February 2, 2023
LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of solid tumors, today announced that Shaun Bagai, Chief Executive Off
PLX, PLBY and THMO Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersJaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100
SLRX, CNET and WISA Among Mid-day Movers
Maxim Group Remains a Buy on RenovoRx (RNXT)
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE:GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.NeuroSense Therapeutics L
NeuroSense, RenovoRx Top Healthcare Gainers; Jupiter Wellness, Surmodics Among Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersApexigen (NASDAQ:APGN) shares moved upwards by 39.7% to $2.5 during Thursday's pre-market session. The company's market cap stands at $56.4 million. Hyperfine (NASDAQ:HYPR) shares increased by
RenovoRx (NASDAQ:RNXT) Stock Price Down 7.6%
RenovoRx, Inc. (NASDAQ:RNXT – Get Rating)'s stock price traded down 7.6% during trading on Wednesday . The stock traded as low as $3.54 and last traded at $3.65. 354,715 shares traded hands during tr
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Ontrak, Inc. (NASDAQ:OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+ progra
Company Overview
More
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
CEO： Mr. Shaun R. Bagai
Market： NASDAQ
Listing Date： 08/26/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet